Foresite Capital Management III as of March 31, 2021
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 8 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aclaris Therapeutics (ACRS) | 43.3 | $49M | 2.0M | 25.20 | |
| Acceleron Pharma | 12.9 | $15M | 109k | 135.61 | |
| Natera (NTRA) | 11.4 | $13M | 127k | 101.54 | |
| Fibrogen (FGEN) | 9.3 | $11M | 306k | 34.71 | |
| Verona Pharma Sponsored Ads (VRNA) | 8.2 | $9.3M | 1.1M | 8.36 | |
| Epizyme | 7.6 | $8.7M | 998k | 8.71 | |
| Cymabay Therapeutics | 6.5 | $7.5M | 1.6M | 4.54 | |
| Novavax (NVAX) | 0.8 | $907k | 5.0k | 181.40 |
